Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Am J Infect Control ; 50(12): 1346-1351, 2022 12.
Article in English | MEDLINE | ID: mdl-35569613

ABSTRACT

BACKGROUND: Clostridioides difficile is the most prevalent hospital-onset (HO) infection. There are significant financial and safety impacts associated with HO-C. difficile infections (HO-CDIs) for both patients and health care organizations. The incidence of HO-CDIs at our community hospital within an academic acute health care system was continuously above the national benchmark. METHODS: In response to the high HO-CDI rates at our facility, an interprofessional team selected evidence-based interventions with the goal of reducing HO-CDI incidence rates. Interventions included: diagnostic stewardship, enhanced environmental cleaning, antimicrobial stewardship and education and accountability. RESULTS: After one year, we achieved a 63% reduction in HO-CDI and have sustained a 77% reduction. The infection rate remained below national benchmark for HO-CDI for over 4 years at a rate of 2.80 per 10,000 patient days and a SIR of 0.43 in 2020. DISCUSSION: Multiple evidence-based interventions were successfully implemented over several service lines over a 4-year period through the collaboration of an interprofessional team. The addition of an accountability processes further improved compliance with standards of practice. CONCLUSIONS: Collaboration of an interprofessional team led to substantial and sustained reductions in HO-CDI.


Subject(s)
Antimicrobial Stewardship , Clostridioides difficile , Clostridium Infections , Cross Infection , Humans , Clostridium Infections/diagnosis , Clostridium Infections/epidemiology , Clostridium Infections/prevention & control , Cross Infection/prevention & control , Cross Infection/epidemiology , Hospitals
2.
Pharmacotherapy ; 36(2): 166-73, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26799442

ABSTRACT

STUDY OBJECTIVES: To determine whether intraoperative continuous-infusion (CI) cefazolin reduces the incidence of surgical site infections (SSIs) compared with intermittent (INT) cefazolin dosing in patients undergoing coronary artery bypass grafting (CABG) on cardiopulmonary bypass (CPB); safety end points and protocol adherence comparing the two dosing strategies were also explored. DESIGN: Retrospective quasi-experimental (pre-post intervention) cohort study. SETTING: Large academic medical center. PATIENTS: A total of 516 adults who underwent CABG on CPB and received cefazolin intraoperatively between June 1, 2013, and December 31, 2014, were included. The INT cohort included 284 patients who underwent CABG from June 2013 to February 2014. The CI cohort included 232 patients who underwent CABG from April to December 2014, after an intraoperative CI cefazolin protocol for cardiac surgery patients undergoing CPB was adopted in March 2014. MEASUREMENTS AND MAIN RESULTS: The primary end point was incidence of SSIs, and safety end points of renal dysfunction and seizures were evaluated. Multivariable logistic regression analysis was used to determine the impact on SSIs when controlling for other risk factors. A subgroup analysis for this study included 2 months within each time period to evaluate protocol adherence. The overall incidence of SSIs was decreased in patients receiving CI cefazolin, although this did not reach statistical significance (4.6% in the INT cohort vs 1.7% in the CI cohort, p=0.116). Superficial SSIs were significantly reduced in the CI cohort (2.8% in the INT cohort vs 0.4% in the CI cohort, p=0.039). In the regression analysis, CI cefazolin decreased the odds of SSI by 66%, although it did not reach statistical significance (p=0.077). Safety end points were not significantly different between groups. Overall protocol adherence did not differ significantly between the cohorts: 77% in the INT cohort and 67% in the CI cohort (p=0.212). CONCLUSION: CI cefazolin significantly decreased the incidence of superficial SSIs compared with INT cefazolin in patients undergoing CABG on CPB, without increasing the risk for adverse effects. As this study was underpowered to detect a significant difference in overall SSIs, larger, randomized studies are required to validate the superiority of CI cefazolin.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Antibiotic Prophylaxis , Cefazolin/administration & dosage , Coronary Artery Bypass/adverse effects , Intraoperative Care , Surgical Wound Infection/prevention & control , Academic Medical Centers , Aged , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis/adverse effects , Baltimore/epidemiology , Cefazolin/adverse effects , Cefazolin/therapeutic use , Cohort Studies , Female , Humans , Incidence , Infusions, Intravenous , Intraoperative Care/adverse effects , Male , Middle Aged , Retrospective Studies , Risk Factors , Severity of Illness Index , Surgical Wound Infection/epidemiology , Surgical Wound Infection/physiopathology
3.
Article in English | MEDLINE | ID: mdl-25960920

ABSTRACT

OBJECTIVE: To develop, teach and evaluate a training workshop that could rapidly prepare large numbers of health professionals working in hospitals in the Philippines to detect and safely manage Ebola virus disease (EVD). The strategy was to train teams (each usually with five members) of key health professionals from public, private and local government hospitals across the Philippines who could then guide Ebola preparedness in their hospitals. METHODS: The workshop was developed collaboratively by the Philippine Department of Health and the country office of the World Health Organization. It was evaluated using a pre- and post-workshop test and two evaluation forms. χ(2) tests and linear regression analyses were conducted comparing pre- and post-workshop test results. RESULTS: A three-day workshop was developed and used to train 364 doctors, nurses and medical technologists from 78 hospitals across the Philippines in three initial batches. Knowledge about EVD increased significantly (P < 0.009) although knowledge on transmission remained suboptimal. Confidence in managing EVD increased significantly (P = 0.018) with 96% of participants feeling more prepared to safely manage EVD cases. DISCUSSION: The three-day workshop to prepare hospital staff for EVD was effective at increasing the level of knowledge about EVD and the level of confidence in managing EVD safely. This workshop could be adapted for use as baseline training in EVD in other developing countries to prepare large numbers of hospital staff to rapidly detect, isolate and safely manage EVD cases.


Subject(s)
Disease Outbreaks/prevention & control , Education, Medical, Continuing/methods , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/therapy , Personnel, Hospital/education , Adult , Disaster Planning/organization & administration , Female , Health Knowledge, Attitudes, Practice , Hemorrhagic Fever, Ebola/prevention & control , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Male , Middle Aged , Philippines , Program Evaluation , Regression Analysis , Self Efficacy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL